Successful treatment of chronic adult T-cell leukemia with ubenimex

Acta Haematol. 1992;87(1-2):94-7. doi: 10.1159/000204727.

Abstract

A 38-year-old Japanese man had suffered from trichophyton infection for several years. The white blood cell count was 20,300/mm3, including 54% abnormal lymphocytes with irregularly convoluted nuclei. Adult T-cell leukemia (ATL) was diagnosed based on proliferation of CD4-positive lymphocytes, positive anti-HTLV-I antibody and monoclonal integration of proviral DNA. By 30 mg/day of ubenimex (Bestatin), the abnormal lymphocytes positive for CD4 in the peripheral blood were gradually reduced. Complete remission was maintained for 9 months without any antineoplastic agents. Ubenimex may have suppressed the growth of ATL cells in this patient. Accordingly, ubenimex may prove useful for treating some patients with chronic-type ATL.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibiotics, Antineoplastic / therapeutic use*
  • CD4-Positive T-Lymphocytes / pathology
  • HTLV-I Antibodies / analysis
  • Humans
  • Leucine / analogs & derivatives*
  • Leucine / therapeutic use
  • Leukemia, Prolymphocytic, T-Cell / drug therapy*
  • Leukemia, Prolymphocytic, T-Cell / microbiology
  • Leukemia, Prolymphocytic, T-Cell / pathology
  • Leukocyte Count
  • Male
  • Remission Induction

Substances

  • Antibiotics, Antineoplastic
  • HTLV-I Antibodies
  • Leucine
  • ubenimex